Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but no invasive ventilation. In an early benefit…
Read More
Researchers identify SARS-CoV-2 antiviral compounds using protein assay
On March 11, 2020, the World Health Organization (WHO) announced the coronavirus disease 2019 (COVID-19) to be a pandemic. COVID-19 is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, which is deemed to be highly contagious…
Read More
Remdesivir shortens recovery time from COVID-19 by FIVE days
Remdesivir shortens recovery time from COVID-19 by FIVE days and reduces the risk of death by 30%, final results of NIH study show Researchers compared hospitalized coronavirus patients who received antiviral drug remdesivir to those who were given a placebo…
Read More
Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients
INDIANAPOLIS, Sept. 14, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today initial data emerging from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National…
Read More
Coronavirus study to trial vaccine delivery through inhalers
A small coronavirus clinical study has been launched in the UK this week to explore the effects of delivering vaccines directly to the body’s airways using an inhaler. Imperial College London researchers said they will assess the safety and effectiveness…
Read More
Coronavirus: China millennials drink milk to boost immunity
One debate fuelled by the virus is about whether to have steamed buns and congee (porridge) for breakfast, or milk and toast. It’s a serious question in China, where the government is pushing people to drink milk to get more…
Read More
Clinicians turn to cocktail of drugs for severe cases
Clinicians across the country are using a combination of treatments to prevent severe disease and deaths among people with moderate to severe symptoms, often following distinct strategies that demonstrate the challenge Covid-19 presents for doctors, who usually chart treatment plans…
Read More
Covid-19: New coronavirus vaccine candidate induces immune response in mice, primates
Scientists, including one of Indian-origin, have developed a COVID-19 vaccine candidate, which they say generates antibodies that “potently neutralise” the novel coronavirus in mice and primates with a single immunisation. The researchers, including Amit Khandhar from the US-based biotech company…
Read More
Coronavirus: Hydroxychloroquine ineffective against mild Covid-19
The malaria drug touted by U.S. President Donald Trump as a COVID-19 treatment was ineffective for patients with a mild version of the disease in a study conducted by researchers at the University of Minnesota. About 24% of the patients…
Read More
Coronavirus: High blood sugar without previous diabetes diagnosis linked to Covid-19 death risk
Patients with COVID-19 who have elevated blood sugar levels without a previous diagnosis of diabetes may be at a high risk of death and an increased risk of severe complications from the infectious disease, a new study says. According to…
Read More